Biotech | March 18, 2022
Sanofi moves forward with EUROAPI listing on Euronext Paris
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)
Rapid testing produces air sample results in 30 minutes
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Subscribe To Our Newsletter & Stay Updated
